# HALT (NCT03256981)

> Stereotactic Body Radiotherapy for the Treatment of OPD

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: oligoprogressive oncogene-addicted NSCLC

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03256981
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Institute of Cancer Research, United Kingdom
- Conditions: NSCLC
- Interventions: SBRT; TKI
- Enrollment: 113
- Primary outcome: Progression free survival

## Indexed commentary on HALT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 55 posts on X
- 8 YouTube videos
- 1 podcast episode
- 1 video on X

## Order

Deep, $1,950 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=halt-nct03256981

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03256981", "email": "<work email>"}; the inbox owner confirms by the emailed link.